COMMUNICATION
|
doi:10.20944/preprints202409.0382.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
salivary gland cancer; HER2; trastuzumab; TDM1; ado-trastuzumab emtansine; trastuzumab deruxtecan
Online: 4 September 2024 (16:05:04 CEST)
ARTICLE
|
doi:10.20944/preprints202304.0002.v1
Subject:
Biology And Life Sciences,
Biochemistry And Molecular Biology
Keywords:
trastuzumab; trastuzumab resistance; HER2; breast cancer; proteomic analysis; metabolic reprogramming.
Online: 3 April 2023 (02:19:25 CEST)
REVIEW
|
doi:10.20944/preprints201902.0043.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
ADC; HM2-MMAE; (vic-)trastuzumab duocarmazine; Trastuzumab deruxtecan; TAK-522; Trastuzumab emtansine; anti-HER2/PBD-MA; HER2 low; HER2-low; mode of action
Online: 4 February 2019 (17:01:31 CET)
ARTICLE
|
doi:10.20944/preprints202112.0441.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
HER2; neoadjuvant; pathologic complete response; trastuzumab
Online: 28 December 2021 (09:58:26 CET)
COMMUNICATION
|
doi:10.20944/preprints202402.1423.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
HER2+ breast cancer, monoclonal antibodies, trastuzumab biosimilars.
Online: 26 February 2024 (10:20:30 CET)
ARTICLE
|
doi:10.20944/preprints202207.0371.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
biosymilars; metastatic breast cancer; trastuzumab; cost; her2; PTH
Online: 25 July 2022 (10:05:29 CEST)
REVIEW
|
doi:10.20944/preprints202405.2073.v1
Subject:
Medicine And Pharmacology,
Cardiac And Cardiovascular Systems
Keywords:
trastuzumab; LV ejection fraction (LVef); immune-mediated; her2; cardiotoxicity
Online: 31 May 2024 (09:12:22 CEST)
ARTICLE
|
doi:10.20944/preprints202402.1308.v1
Subject:
Medicine And Pharmacology,
Pediatrics, Perinatology And Child Health
Keywords:
health-related quality of life (HRQoL); pediatric traumatic brain injury (TBI); QOLIBRI-KID/ADO
Online: 22 February 2024 (13:22:09 CET)
REVIEW
|
doi:10.20944/preprints202401.0676.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
HER2; breast cancer; breast neoplasms; antibody-drug conjugate; ADCs; trastuzumab emtansine; trastuzumab deruxtecan; disitamab Vedotin; ARX-788; SYD985; BL-M0701; zanidatamab zovodotin.
Online: 9 January 2024 (10:29:59 CET)
ARTICLE
|
doi:10.20944/preprints202306.0676.v1
Subject:
Physical Sciences,
Biophysics
Keywords:
Trastuzumab; Pertuzumab; HER2; Binding Free Energy; PRODIGY; Size Exclusion Chromatography
Online: 9 June 2023 (07:01:32 CEST)
ARTICLE
|
doi:10.20944/preprints202102.0545.v1
Subject:
Biology And Life Sciences,
Biochemistry And Molecular Biology
Keywords:
trastuzumab, HER2, extracellular vesicles, breast cancer, proteomic analysis, immunoelectron microscopy, TOP1, CD63, mitochondria.
Online: 24 February 2021 (11:38:41 CET)
REVIEW
|
doi:10.20944/preprints202409.0327.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Breast cancer; HER2; Trastuzumab; Pertuzumab; De-escalation; Personalized medicine; Targeted therapies; Adjuvant therapies; Neoadjuvant therapies
Online: 5 September 2024 (04:54:49 CEST)
REVIEW
|
doi:10.20944/preprints202306.0932.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
gastric cancer; HER2; immunotherapy; PD-1/PD-L1; antibody-drug conjugate; chemotherapy; trastuzumab; novel therapies; clinical trials
Online: 13 June 2023 (11:15:24 CEST)
ARTICLE
|
doi:10.20944/preprints201904.0205.v1
Subject:
Chemistry And Materials Science,
Analytical Chemistry
Keywords:
antibody coating; proximity-enhanced reaction; immunoglobulins; IgG; protein A; protein G; bio-interaction; immunoprecipitation; pull-down assay; immunocapture; stabilization; yield; regeneration; nanoparticles; microparticles; biochips; immunosensor; photochemical crosslinker; click chemistry; herceptin; trastuzumab
Online: 18 April 2019 (07:55:11 CEST)